The Private Equity team advised SunMed Group Holdings d/b/a AirLife, a portfolio company of Frazier Healthcare Partners, on the completion of its acquisition of Avanos Medical, including the BALLARD*, MICROCUFF* and endOclear® product lines.
The acquisition adds three complementary brands, the R&D expertise behind them and two manufacturing facilities into AirLife’s growing platform. The transaction advances AirLife’s strategy to enhance its leading portfolio of the most trusted products in anesthesia and respiratory care and serve even more customers as a one-stop source for the highest-quality consumable breathing solutions that support the best patient outcomes.
AirLife was acquired by Frazier in June 2021 and is a producer and distributor of anesthesia and respiratory medical products, including airway management, anesthesia, respiratory, resuscitation/ventilation, diagnostics, oxygen delivery and surgical care products. AirLife operates primarily in the United States and serves over 70 countries. For more than 40 years, AirLife has expanded its brands to offer one of the most comprehensive collections of respiratory and anesthesia products on the market.
Founded in 1991, Frazier is a leading provider of growth capital to healthcare companies. The firm has made investments in more than 170 healthcare companies, with investment types ranging from company creation and venture capital to growth buyouts and leveraged recapitalizations. Frazier’s experienced team takes an active approach to help build portfolio companies, leveraging the team’s deep domain expertise and expansive network of healthcare executives, advisors and industry leaders.
The Goodwin team was led by Jared Spitalnick, Michael Miller, Matthew Giannascoli, David Gallagher, Daniel Marks, Jessica Barbaria and Kirsten Kovats (Corporate), and included Jennifer Bralower, Anne Bandes, Emily Josef and Carlos Martinez (Debt Finance), with support from Goodwin’s United Kingdom, France and Germany offices.
For additional details on the acquisition, please read the press release.